The quest for transparency in the relationships between life sciences companies and healthcare professionals is quickly becoming a global movement. Reporting requirements for financial interactions have been prevalent in the United States for many years, but the movement is spreading throughout the world to places like Japan, Australia, and Europe. In France, the government passed a law that imposes burdensome reporting requirements. Industry groups across Europe, most notably the European Federation of Pharmaceutical Industries and Associations, are acting aggressively to try to forestall more government laws by adopting industry-developed disclosure systems. These activities will affect many different segments of the European healthcare system.
Editor-in-Chief
Co-Editors
Managing Editor
Victoria White
Associate Editors
Section Editors
Digital Communication
EMWA News
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
In the Bookstores
Manuscript Writing
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Out on Our Own
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Teaching Medical Writing
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Lay out Designer
Chris Monk